Relmada Therapeutics Inc (STU:4E2)
€ 0.59 +0.065 (+12.38%) Market Cap: 20.33 Mil Enterprise Value: -2.72 Mil PE Ratio: 0 PB Ratio: 0.97 GF Score: 41/100

Relmada Therapeutics Inc (STU:4E2) Transcripts

  • 1